BCSAX | EIPCX | BCSAX / EIPCX | |
Total Expense Ratio | 0.97 | 0.68 | 143% |
Annual Report Gross Expense Ratio | 1.12 | 0.68 | 165% |
Fund Existence | 14 years | 14 years | - |
Gain YTD | 9.721 | 8.279 | 117% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 633M | 1.73B | 37% |
Annual Yield % from dividends | 3.09 | 5.26 | 59% |
Returns for 1 year | 8.44 | 9.80 | 86% |
Returns for 3 years | -0.02 | 7.83 | -0% |
Returns for 5 years | 108.23 | 137.99 | 78% |
Returns for 10 years | 52.88 | 83.00 | 64% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
THW | 11.26 | -0.01 | -0.09% |
abrdn World Healthcare Fund | |||
IBHI | 22.83 | -0.36 | -1.55% |
iShares iBonds 2029 Term HY & Inc ETF | |||
FMED | 22.95 | -0.62 | -2.62% |
Fidelity Disruptive Medicine ETF | |||
FDWM | 20.70 | -1.27 | -5.76% |
Fidelity Women's Leadership ETF | |||
ESML | 36.53 | -2.70 | -6.88% |
iShares ESG Aware MSCI USA Small-Cap ETF |